Risk factors for recurrence of ovarian endometriomas after surgical treatment: retrospective cohort study

Aim. To identify risk factors for recurrence of ovarian endometriomas after surgical treatment.Materials and methods. The retrospective cohort study included 82 patients operated on for the first time for ovarian endometriomas, the follow-up period was 30 months. The recurrence developed in 19 patie...

Full description

Bibliographic Details
Main Authors: T. S. Kachalina, M. E. Bogatova, S. S. Kuznetsov, V. F. Lazukin
Format: Article
Language:Russian
Published: Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University) 2021-04-01
Series:Сеченовский вестник
Subjects:
Online Access:https://www.sechenovmedj.com/jour/article/view/301
_version_ 1797873673647947776
author T. S. Kachalina
M. E. Bogatova
S. S. Kuznetsov
V. F. Lazukin
author_facet T. S. Kachalina
M. E. Bogatova
S. S. Kuznetsov
V. F. Lazukin
author_sort T. S. Kachalina
collection DOAJ
description Aim. To identify risk factors for recurrence of ovarian endometriomas after surgical treatment.Materials and methods. The retrospective cohort study included 82 patients operated on for the first time for ovarian endometriomas, the follow-up period was 30 months. The recurrence developed in 19 patients (group 1), in 63 the recurrence was not diagnosed (group 2). Data prior to surgery (clinical characteristics, level CA-125), during surgery (cytokine concentration in peritoneal fluid, immunohistochemical analysis in capsule of ovarian endometriomas), postoperative therapy were evaluated as risk factors for recurrence. The Mann-Whitney U-test, the Fisher exact test was used to compare the groups. Specificity, sensitivity, accuracy, AUC ROC and threshold values were calculated.Results. The recurrence rate of ovarian endometriomas was 23%. There were no differences between groups according to age, proportion of smokers, body mass index, gynecological anamnesis, obstetric status and postoperative hormone therapy. Preoperative concentrations of CA-125 in group 1 were higher than in group 2: 62.5 U/ml [40.7; 112.3] vs 40.3 U/ml [20.3; 68.8], р < 0.05. The concentration of IL-6, IL-8, TNFα, IL-1β, IL-17, VEGF, MCP 1 in peritoneal fluid taken during surgery was statistically significantly higher in group 1. The highest AUC ROC was received for VEGF 0.875 (0.778–0.973) and IL-8 0.953 (0.896–1.009). For VEGF the threshold value was 125.6 pg/ml, sensitivity 100%, specificity 71%, accuracy 79.8%. For IL-8 the threshold value was 128.78 pg/ml, sensitivity 93%, specificity 87.1%, accuracy 88.9%. In group 1, higher expression values of VEGF and CD34 angiogenesis markers in ovarian endometriomas were recorded. The highest AUC ROC was noted for CD34 — 0.844 (0.683–1.000), threshold value was 2.5%, sensitivity 90%, specificity 75%, accuracy 80.8%.Conclusion. Risk factors for recurrence of ovarian endometriomas after operative treatment include VEGF and IL-8 levels in peritoneal fluid and expression of CD34 in the capsule.
first_indexed 2024-04-10T01:19:58Z
format Article
id doaj.art-c1acdcb6b89b4b1ab600d0189d3dc4ff
institution Directory Open Access Journal
issn 2218-7332
2658-3348
language Russian
last_indexed 2024-04-10T01:19:58Z
publishDate 2021-04-01
publisher Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
record_format Article
series Сеченовский вестник
spelling doaj.art-c1acdcb6b89b4b1ab600d0189d3dc4ff2023-03-13T09:51:34ZrusFederal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)Сеченовский вестник2218-73322658-33482021-04-01114607110.47093/2218-7332.2020.11.4.60-71165Risk factors for recurrence of ovarian endometriomas after surgical treatment: retrospective cohort studyT. S. Kachalina0M. E. Bogatova1S. S. Kuznetsov2V. F. Lazukin3Privolzhsky Research Medical UniversityCity Clinical Hospital No. 29 of the Prioksky district of Nizhny NovgorodN.A. Semashko Nizhny Novgorod Regional Clinical HospitalPrivolzhsky Research Medical UniversityAim. To identify risk factors for recurrence of ovarian endometriomas after surgical treatment.Materials and methods. The retrospective cohort study included 82 patients operated on for the first time for ovarian endometriomas, the follow-up period was 30 months. The recurrence developed in 19 patients (group 1), in 63 the recurrence was not diagnosed (group 2). Data prior to surgery (clinical characteristics, level CA-125), during surgery (cytokine concentration in peritoneal fluid, immunohistochemical analysis in capsule of ovarian endometriomas), postoperative therapy were evaluated as risk factors for recurrence. The Mann-Whitney U-test, the Fisher exact test was used to compare the groups. Specificity, sensitivity, accuracy, AUC ROC and threshold values were calculated.Results. The recurrence rate of ovarian endometriomas was 23%. There were no differences between groups according to age, proportion of smokers, body mass index, gynecological anamnesis, obstetric status and postoperative hormone therapy. Preoperative concentrations of CA-125 in group 1 were higher than in group 2: 62.5 U/ml [40.7; 112.3] vs 40.3 U/ml [20.3; 68.8], р < 0.05. The concentration of IL-6, IL-8, TNFα, IL-1β, IL-17, VEGF, MCP 1 in peritoneal fluid taken during surgery was statistically significantly higher in group 1. The highest AUC ROC was received for VEGF 0.875 (0.778–0.973) and IL-8 0.953 (0.896–1.009). For VEGF the threshold value was 125.6 pg/ml, sensitivity 100%, specificity 71%, accuracy 79.8%. For IL-8 the threshold value was 128.78 pg/ml, sensitivity 93%, specificity 87.1%, accuracy 88.9%. In group 1, higher expression values of VEGF and CD34 angiogenesis markers in ovarian endometriomas were recorded. The highest AUC ROC was noted for CD34 — 0.844 (0.683–1.000), threshold value was 2.5%, sensitivity 90%, specificity 75%, accuracy 80.8%.Conclusion. Risk factors for recurrence of ovarian endometriomas after operative treatment include VEGF and IL-8 levels in peritoneal fluid and expression of CD34 in the capsule.https://www.sechenovmedj.com/jour/article/view/301ovarian endometriomarisk factors of recurrencerecurrencecarbohydrate antigen 125 (ca-125)peritoneal fluidvascular endothelial growth factor (vegf)interleukin 8 (il-8)cd34
spellingShingle T. S. Kachalina
M. E. Bogatova
S. S. Kuznetsov
V. F. Lazukin
Risk factors for recurrence of ovarian endometriomas after surgical treatment: retrospective cohort study
Сеченовский вестник
ovarian endometrioma
risk factors of recurrence
recurrence
carbohydrate antigen 125 (ca-125)
peritoneal fluid
vascular endothelial growth factor (vegf)
interleukin 8 (il-8)
cd34
title Risk factors for recurrence of ovarian endometriomas after surgical treatment: retrospective cohort study
title_full Risk factors for recurrence of ovarian endometriomas after surgical treatment: retrospective cohort study
title_fullStr Risk factors for recurrence of ovarian endometriomas after surgical treatment: retrospective cohort study
title_full_unstemmed Risk factors for recurrence of ovarian endometriomas after surgical treatment: retrospective cohort study
title_short Risk factors for recurrence of ovarian endometriomas after surgical treatment: retrospective cohort study
title_sort risk factors for recurrence of ovarian endometriomas after surgical treatment retrospective cohort study
topic ovarian endometrioma
risk factors of recurrence
recurrence
carbohydrate antigen 125 (ca-125)
peritoneal fluid
vascular endothelial growth factor (vegf)
interleukin 8 (il-8)
cd34
url https://www.sechenovmedj.com/jour/article/view/301
work_keys_str_mv AT tskachalina riskfactorsforrecurrenceofovarianendometriomasaftersurgicaltreatmentretrospectivecohortstudy
AT mebogatova riskfactorsforrecurrenceofovarianendometriomasaftersurgicaltreatmentretrospectivecohortstudy
AT sskuznetsov riskfactorsforrecurrenceofovarianendometriomasaftersurgicaltreatmentretrospectivecohortstudy
AT vflazukin riskfactorsforrecurrenceofovarianendometriomasaftersurgicaltreatmentretrospectivecohortstudy